| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |